Market Overview

15 Biggest Mid-Day Losers For Tuesday

  • Ra Pharmaceuticals Inc (NASDAQ: RARX) shares dipped 22 percent to $17.30 after the company issued updates on Phase 2 trial of RA101495.
  • Xenon Pharmaceuticals Inc (NASDAQ: XENE) shares dropped 20.6 percent to $3.02 after the company reported results from Phase II study of TV-45070 in patients with PHN. The study did not meet primary and secondary endpoints.
  • Rewalk Robotics Ltd (NASDAQ: RWLK) shares dropped 18.3 percent to $2.45 after surging 25.00 percent on Monday.
  • Alder Biopharmaceuticals Inc (NASDAQ: ALDR) shares declined 17.7 percent to $15.40 despite PROMISE 1 Phase 3 trial which met primary and secondary endpoints. Several notable parts of data set were concerning, namely statistical significance for 100mg dose, and against placebo.
  • Camtek LTD. (NASDAQ: CAMT) shares dipped 12.3 percent to $5.18 after rising 2.25 percent on Monday.
  • Finjan Holdings, Inc. (NASDAQ: FNJN) dropped 12.2 percent to $3.18. Finjan priced 3.6 million shares at $3.15 per share.
  • Matinas BioPharma Holdings Inc (NYSE: MTNB) shares declined 11 percent to $1.78.
  • Presbia PLC (NASDAQ: LENS) shares fell 10.9 percent to $2.41.
  • Digiliti Money Group Inc (NASDAQ: DGLT) shares declined 10.1 percent to $2.97.
  • Shiloh Industries, Inc. (NASDAQ: SHLO) shares slipped 9.7 percent to $12.77.
  • IMPINJ Inc (NASDAQ: PI) shares dropped 9.5 percent to $53.76. Pacific Crest downgraded Impinj from Overweight to Sector Weight.
  • Avis Budget Group Inc. (NASDAQ: CAR) shares fell 8.2 percent to $25.39. Avis announced Monday it has formed a partnership with Alphabet Inc (NASDAQ: GOOGL)’s autonomous car business, Waymo.
  • WhiteHorse Finance Inc (NASDAQ: WHF) slipped 6.6 percent to $13.43. WhiteHorse Finance reported an offering of 2.5 million shares of common stock.
  • ARMOUR Residential REIT, Inc. (NYSE: ARR) shares declined 5 percent to $26.11. ARMOUR Residential REIT reported a 4.5 million share common stock offering.
  • Neos Therapeutics Inc (NASDAQ: NEOS) shares declined 4.8 percent to $7.00. Neos Therapeutics reported a $30 million offering of common stock.

Related Articles (ARR + ALDR)

View Comments and Join the Discussion!

Posted-In: Mid-Day LosersNews Movers & Shakers Intraday Update Markets Movers